Home Tools
Log in
Cart

Search Result

Search Results for " ifosfamide "

7

Compounds

Cat No. Product Name Synonyms Targets
T1055 Ifosfamide NSC109724,Isophosphamide DNA Alkylator/Crosslinker , DNA/RNA Synthesis
Ifosfamide (NSC-109724) alkylates and forms DNA crosslinks, thereby preventing DNA strand separation and DNA replication. Ifosfamide is a synthetic analog of the nitrogen mustard cyclophosphamide with antineoplastic acti...
T25723 L-Ifosfamide (+)-Ifosfamide
L-Ifosfamide is nitrogen mustard, a chemotherapeutic antineoplastic, and more precisely an alkylating agent structural analog of cyclophosphamide with respect to which presents some differences regard to the antitumor ac...
T4350 Palifosfamide ZIO-201,Isophosphamide mustard,Isophosphoramide mustard DNA Alkylator/Crosslinker , DNA Alkylation , Drug Metabolite
Palifosfamide (Isophosphamide mustard) lysine (ZIO-201) is a stable form of palifosfamide. Palifosfamide lysine has broad activity in sarcoma lines in vitro. The IC50 ranges from 2.25 to 6.75 μM for most cell lines excep...
T29851 Aldoifosfamide UNII-S1JX147O5E,Mitoxana,Ifex
Aldoifosfamide is a metabolite of ifosfamide. Ifosfamide (also marketed as Mitoxana and Ifex) is a nitrogen mustard alkylating agent used in the treatment of cancer. It is sometimes abbreviated 'IFO''.
T71500 Palifosfamide tromethamine IPM tromethamine,Isophosphoramide mustard tromethamine,ZIO-201 tromethamine,Isophosphoramide mustard tromethamine ; IPM tromethamine ; ZIO-201 tromethamine
Palifosfamide (tromethamine), a synthetically derived alkylating agent, exhibits potential antineoplastic properties. Acting as the stabilized active metabolite of ifosfamide, it irreversibly alkylates and crosslinks DNA...
T83317 4-Hydroperoxyifosfamide
4-Hydroperoxyifosfamide is an anticancer agent capable of penetrating the blood-brain barrier (BBB) [1].
T1414 Sodium 2-mercaptoethanesulfonate Mitexan,Uromitexan,Mesna,Mesnum,Mesnex Others
Sodium 2-mercaptoethanesulfonate (Uromitexan) is a sulfhydryl compound used to prevent urothelial toxicity by inactivating metabolites from antineoplastic agents, such as ifosfamide or cyclophosphamide.
TargetMol